H. Lundbeck A/S B (HLUN-B.CO) Financials
HLUN-B.CO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2022-12-31 | 37.5 billion | 16.7 billion |
2022-09-30 | 39.3 billion | 18.4 billion |
2022-06-30 | 37.3 billion | 17.7 billion |
2022-03-31 | 35.1 billion | 16.6 billion |
HLUN-B.CO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2022-12-31 | 751.0 million | ? |
2022-09-30 | 1.4 billion | ? |
2022-06-30 | 852.0 million | ? |
2022-03-31 | -292.0 million | ? |
HLUN-B.CO Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2022-12-31 | 311.0 million |
2022-09-30 | 688.0 million |
2022-06-30 | 505.0 million |
2022-03-31 | 412.0 million |
HLUN-B.CO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2022-12-31 | - | - | 483.0 million |
2022-09-30 | - | - | 518.0 million |
2022-06-30 | - | - | 518.0 million |
2022-03-31 | - | - | 526.0 million |
HLUN-B.CO Shares Outstanding
HLUN-B.CO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2022-12-31 | 536.0 million | 905.0 million | 2.2 billion | - |
2022-09-30 | 133.0 million | 906.0 million | 1.9 billion | - |
2022-06-30 | 64.0 million | 962.0 million | 1.9 billion | - |
2022-03-31 | 87.0 million | 981.0 million | 1.7 billion | - |
HLUN-B.CO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2022-12-31 | 4.7 billion | 1.2 billion |
2022-09-30 | 4.7 billion | 961.0 million |
2022-06-30 | 4.5 billion | 966.0 million |
2022-03-31 | 4.4 billion | 845.0 million |
HLUN-B.CO
Price: DKK35.16
52 week price:
Dividend Yield: 0.02%
5-year range yield:
Forward Dividend Yield: 2.02%
Payout Ratio: 30.30%
Payout Ratio Range:
Dividend Per Share: 0.70 DKK
Earnings Per Share: 2.31 DKK
P/E Ratio: 14.78
Exchange: CPH
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 33.0 billion
Years Paying Dividends: 2